Obesity Cardiomyopathy Identified as Distinct Pathology Linked to Sudden Cardiac Death: JACC

Written By :  Dr. Kamal Kant Kohli
Published On 2023-08-10 05:15 GMT   |   Update On 2023-08-10 06:38 GMT

UK: Based on records from a national referral centre in the UK, the researchers have identified obesity cardiomyopathy (OCM) as a distinct pathology associated with sudden cardiac death (SCD). It is commonly observed in young males with increased body mass index (BMI)."Autopsies revealed that out of more than 6,400 SCDs, 53 people who died of obesity had cardiomegaly without a medical...

Login or Register to read the full article

UK: Based on records from a national referral centre in the UK, the researchers have identified obesity cardiomyopathy (OCM) as a distinct pathology associated with sudden cardiac death (SCD). It is commonly observed in young males with increased body mass index (BMI).

"Autopsies revealed that out of more than 6,400 SCDs, 53 people who died of obesity had cardiomegaly without a medical history indicating a usual aetiology of heart disease," the researchers reported in the study published in JACC: Advances. The mean age at death was 42 years, including 64% of men.

The pathology was suggested as obesity cardiomyopathy, characterized by right ventricular (RV) hypertrophy and symmetrical left ventricular (LV) hypertrophy in the absence of infiltrative disease Or myocyte disarray. Fibrosis was seen in only a minority of cases.

"There is no full understanding of the cause of OCM associated with SCD," the researchers wrote. "Only a small proportion of cases had fibrosis on microscopy indicating that SCD in OCM may be mediated through increased ventricular mass."

Previous studies have shown that obesity cardiomyopathy can be associated with sudden cardiac death, but pathologic features have not been described well. Joseph Westaby, St. George's University of London and St George's University Hospitals NHS Foundation Trust, London, United Kingdom, and colleagues, therefore, aimed to characterize the pathological and clinical features of OCM associated with SCD in a retrospective case-control autopsy study.

In the absence of other causes, OCM was identified by an increased heart weight (>550 g in males; >450 g in females) in people with obesity (BMI ≥30 kg/m2). Cases of OCM with SCD were compared to age and sex-matched SCD controls with obesity or with normal weight (BMI 18.5-24.9 kg/m2) and morphologically normal hearts.

Autopsy measures were atrial dimensions, heart weight, epicardial adipose tissue, and ventricular wall thickness. Fibrosis was assessed microscopically.

The study led to the following findings:

  • Of 6,457 SCD cases, 53 cases of OCM were identified and matched to 106 controls with obesity and 106 normal weight controls.
  • The OCM mean age at death of individuals with OCM was 42 ± 12 with a male predominance (n = 34, 64%).
  • Males died younger than females (40 ± 13 versus 45 ± 10).
  • BMI was increased in OCM cases compared to controls with obesity (42 ± 8 versus 35 ± 5).
  • The average heart weight was 598 ± 93 g in OCM.
  • There were increases in right and left ventricular wall thickness in OCM cases compared to controls.
  • Right ventricular epicardial fat was increased in OCM compared to normal weight controls only.
  • Left ventricular fibrosis was identified in 13% of the cases

"Obesity cardiomyopathy may be a specific pathological entity associated with SCD," the researchers wrote. "It is most commonly seen in young males with increased BMI."

"The relevance and basis of OCM as a marker of risk for SCD now requires assessment in population studies," the researchers concluded.

Reference:

Westaby J, et al "Obesity cardiomyopathy in sudden cardiac death: a distinct entity? A comparative study" JACC Adv 2023; DOI: 10.1016/j.jacadv.2023.100414.


Tags:    
Article Source : JACC: Advances

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News